Literature DB >> 11277735

Evaluation of ligand overlap by atomic parameters.

S A Wildman1, G M Crippen.   

Abstract

The overlap of ligand atoms has been analyzed for 32 common enzyme systems. The ligand alignment was determined by superposition of the experimentally determined protein structures. Comparison of the overlapping atoms in terms of atomic contribution to partition coefficient and molar refractivity shows that in most cases ligand atoms overlap with atoms of a similar nature, as should be expected. A new statistic, the mean maximal atomic deviation (MeMAD), is determined and validated for each system studied by comparison to randomized data. In almost all cases, the MeMAD is well separated from the randomized outcome. This result indicates the validity of the atom-based physicochemical parameters in 3-D QSAR methods.

Mesh:

Substances:

Year:  2001        PMID: 11277735     DOI: 10.1021/ci0000880

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  4 in total

1.  Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity.

Authors:  Katie Jo Rohn; Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2012-05-16       Impact factor: 3.922

2.  Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation.

Authors:  Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2010

3.  BCL::MolAlign: Three-Dimensional Small Molecule Alignment for Pharmacophore Mapping.

Authors:  Benjamin P Brown; Jeffrey Mendenhall; Jens Meiler
Journal:  J Chem Inf Model       Date:  2019-02-12       Impact factor: 4.956

4.  Discovery of novel new Delhi metallo-β-lactamases-1 inhibitors by multistep virtual screening.

Authors:  Xuequan Wang; Meiling Lu; Yang Shi; Yu Ou; Xiaodong Cheng
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.